Skip to main content

Table 5 Multivariable in-hospital risk factors associated with mortality and orotracheal intubation in the diabetes patients

From: Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Characteristic In-hospital death risk factors OR (CI 95%) In-hospital orotracheal intubation OR (CI 95%) Covariables included in the logistic analysis
Age
Cardiopathy
CDK
1.072 (1.003–1.15)
7.11 (0.16–3.98)
NS
1.034 (1.001–1.068)
NS
4.95–1.11–22.02)
Age and gender and all comorbidities
Vasoactive drug
CLHO/HCQ
11.73 (3.07–44.87)
3.99 (1.05–15.21)
227.03 (43.19–1193-43)
31.10 (6.43–150-38)
CLHO/HCQ. In-hospital metformin therapy; Pre-hospital metformin therapy; In-hospital insulin therapy; Dexamethasone/prednisolone
NEWS
In-hospital metformin therapy
1.71 (1.18–2.49)
0.034 (0.002–0.58)
NS
NS
Orotracheal intubation; prona; prisma; vasoactive drug, CLHO/HCQ. NEWS, In-hospital metformin therapy; Pre-hospital metformin therapy; In-hospital insulin therapy; Dexamethasone/prednisolone
  1. Neoplasia/immune, Neoplasia/immunosuppression; NEWS, National Early Warning Score; Prisma, prisma hemodialysis machine; Prona, prone position; CLHO/HCQ, Chloroquine/hydroxychloroquine, NS, not significant